You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 11, November 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clonidine and Naltrexone

A Safe, Effective, and Rapid Treatment of Abrupt Withdrawal From Methadone Therapy

Dennis S. Charney, MD; Charles E. Riordan, MD; Herbert D. Kleber, MD; Michele Murburg, MD; Paula Braverman; David E. Sternberg, MD; George R. Heninger, MD; D. Eugene Redmond, MD

Arch Gen Psychiatry. 1982;39(11):1327-1332.


Abstract

• Clonidine hydrochloride and naltrexone hydrochloride, given in combination, were found to provide a safe, effective, and extremely rapid treatment of abrupt withdrawal from methadone hydrochloride therapy. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, ten (91%) of 11 patients were able to withdraw completely from methadone therapy by the end of a six-day period. Six days of clonidine hydrochloride treatment, with a peak mean dose of 2.9 mg/day on treatment day 2, attenuated the withdrawalinducing effects of naltrexone. Naltrexone hydrochloride was gradually increased from an initial 1-mg dose on treatment day 2 to a 50-mg maintenance dose on treatment day 5 without an associated increase in withdrawal symptoms. Clonidine significantly decreased BP without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, and muscular aching were most resistant to treatment, but at discharge most patients were completely asymptomatic.



Author Affiliations

From the Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication April 21, 1982.

Reprint requests to Connecticut Mental Health Center, Yale University School of Medicine, 34 Park St, New Haven, CT 06508 (Dr Charney).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effect of Clonidine on Gastrointestinal Side Effects Associated with Ultra-Rapid Opioid Detoxification
Ma et al.
Anesth. Analg. 2003;96:1409-1412.
ABSTRACT | FULL TEXT  

Activation of Coeruleospinal Noradrenergic Inhibitory Controls during Withdrawal from Morphine in the Rat
Rohde and Basbaum
J. Neurosci. 1998;18:4393-4402.
ABSTRACT | FULL TEXT  

Methadone Maintenance in the Treatment of Narcotics Addiction
Tommasello
Journal of Pharmacy Practice 1991;4:357-361.
ABSTRACT  

Cerebrospinal Fluid 3-Methoxy-4-hydroxyphenylglycol and Norepinephrine Levels in Alcohol Withdrawal: Correlations With Clinical Signs
Hawley et al.
Arch Gen Psychiatry 1985;42:1056-1062.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.